It is well known that within long-standing multiple sclerosis (MS) lesions
there is axonal loss but whether it is an early or late event has been more
difficult to establish. The use of immunocytochemical methods that reveal
axonal end-bulbs is a valuable approach to investigating acute axonal injur
y in human pathological material. The application of these techniques to mu
ltiple sclerosis tissue reveals evidence of axonal injury in acute lesions;
the distribution of the end-bulbs in acute and active-chronic lesions is a
ssociated with regions of maximal density of infiltrating macrophages. Axon
injury within the MS lesion will result in both Wallerian degeneration of
the axon and also retrograde degeneration of the cell body. The functional
consequences of the axon injury will depend upon numbers of axons injured a
nd the topographical organization of the fibres coursing through the lesion
.
The molecular mechanisms by which the recruited leucocytes damage or transe
ct the axons are not known. However, investigations in the Wld mutant mouse
with very slow Wallerian degeneration demonstrate that axon degeneration i
s not simply a passive disintegration of the axon but has clear parallels w
ith the active processes of programmed cell death. The presence of early ax
on injury and the consequences of an ever increasing load of neuronal damag
e has important implications not only for when therapy should be initiated
in MS but also the therapeutic target.